Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System.
Xiaoming JiaMichelle T LeeDavid J RamseyMahmoud Al RifaiDhruv MahttaChayakrit KrittanawongJulia M AkeroydMichael E MathenyGlenn GobbelNeil J StoneChristie M BallantyneLaura A PetersenSalim S ViraniPublished in: Cardiovascular drugs and therapy (2021)
Significant facility-level variation in SASE reporting was found within the VA healthcare system suggesting room for improvement in standardized documentation of SASEs among medical facilities. This has the potential to lead to improvement in statin utilization.